AZN R&D Expenses

AstraZeneca PLC Ordinary Shares · R&D Expenses

AZN logo

AZN R&D Expenses

Latest reported$15.07B
AZN TTM R&D Expenses ($0.00 → $15.07B)
High-resolution chart · PNG

AZN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
15,070,000,000
14,565,000,000
14,232,000,000
15,047,000,000
14,499,000,000
13,959,000,000
13,583,000,000
11,979,000,000
11,448,000,000
11,107,000,000
10,935,000,000
10,650,000,000
10,524,000,000
10,403,000,000
9,925,000,000
11,282,000,000
12,434,000,000
11,717,000,000
11,297,000,000
9,200,000,000
7,085,000,000
6,645,000,000
6,320,000,000
6,445,000,000
6,296,000,000
6,263,000,000
6,141,000,000
5,980,000,000
5,876,000,000
5,882,000,000
5,895,000,000
5,434,000,000
5,596,000,000
5,583,000,000
5,757,000,000
5,749,000,000
5,747,000,000
5,863,000,000
5,890,000,000
6,093,000,000
6,120,000,000
6,121,000,000
5,997,000,000
5,750,000,000
5,873,000,000
5,735,000,000
5,579,000,000
5,509,000,000
4,815,000,000
4,762,000,000
4,821,000,000
4,712,000,000
5,058,000,000
4,972,000,000
5,243,000,000
5,790,000,000
5,882,000,000
5,891,000,000
5,523,000,000
5,586,000,000
5,367,000,000
5,489,000,000
5,318,000,000
4,702,000,000
4,681,000,000
4,420,000,000
4,409,000,000
4,566,000,000
4,771,000,000
4,977,000,000
5,179,000,000
5,177,000,000
5,243,000,000
5,174,000,000
5,162,000,000
4,817,000,000
4,452,000,000
4,211,000,000
3,902,000,000
3,651,000,000
3,470,000,000
3,375,000,000
3,379,000,000
3,741,000,000
3,783,000,000
3,811,000,000
3,803,000,000
3,610,000,000
3,594,550,220
3,524,710,206
3,450,999,998
3,305,783,769
3,242,354,440
3,147,194,454
3,060,904,662
4,170,523,468
4,040,402,577
3,986,402,577
3,959,224,958
3,008,801,081
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.